Chan XHS, Win YN, Mawer LJ, et al. Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for malaria: a systematic review and Bayesian meta-analysis. Lancet Infect Dis 2018; 18 913–23—In figure 3 on page 8 of the results section in this Article, the y-axis label for the middle graph should be ‘Deaths within 30 days from dihydroartemisinin—piperaquine administration’. Additionally, the drug name in the title for table 2 should be ‘dihydroartemisinin–piperaquine’, and the author name for reference 27 should be ‘Stan Development Team.’ These corrections have been made to the online version as of June 26, 2018.
. 2018 Aug;18(8):829. doi: 10.1016/S1473-3099(18)30419-5
Corrections
© 2018 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC6880286 PMID: 29958831
This corrects the article "Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for malaria: a systematic review and Bayesian meta-analysis" on page 913.